Yanger Kilangsungla, Knigin David, Zong Yiwei, Maggs Lara, Gu Guoqiang, Akiyama Haruhiko, Pikarsky Eli, Stanger Ben Z
Department of Medicine, Gastroenterology Division, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA; Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Department of Immunology and Cancer Research and Department of Pathology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel; Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem 91120, Israel.
Cell Stem Cell. 2014 Sep 4;15(3):340-349. doi: 10.1016/j.stem.2014.06.003. Epub 2014 Aug 14.
The liver is thought to utilize facultative stem cells, also known as "oval cells" or "atypical ductal cells" (ADCs), for regeneration following various types of injury. However, this notion has been based largely on in vitro studies and transplantation models; where lineage tracing has been used, results have been conflicting and effect sizes have been small. Here, we used genetic and nucleoside analog-based tools to mark and track the origin and contribution of various cell populations to liver regeneration in vivo following several ADC-inducing insults. We report that, contrary to prevailing stem-cell-based models of regeneration, virtually all new hepatocytes come from preexisting hepatocytes.
肝脏被认为在遭受各种类型损伤后利用兼性干细胞(也称为“卵圆细胞”或“非典型导管细胞”,即ADC)进行再生。然而,这一观点很大程度上基于体外研究和移植模型;在使用谱系追踪的研究中,结果相互矛盾且效应量较小。在此,我们使用基于遗传和核苷类似物的工具来标记和追踪多种细胞群体在几种诱导ADC的损伤后对体内肝脏再生的起源和贡献。我们报告称,与普遍的基于干细胞的再生模型相反,几乎所有新的肝细胞都来自已有的肝细胞。